During the past decade, HCG Bangalore Institute of Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HCG Bangalore Institute of Oncology" #1 sponsor was "Biocad" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Imugene Limited" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HCG Bangalore Institute of Oncology" #1 collaborator was "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "HCG Bangalore Institute of Oncology" are "Breast Cancer" (2 trials), "Lymphoma, Mantle-Cell" (2 trials), "Non-small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "HCG Bangalore Institute of Oncology" in a lesser frequency.

Most popular intervention types in "HCG Bangalore Institute of Oncology" are "Drug" (11 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (2 trials), "Paclitaxel" (2 trials), "Abemaciclib" (1 trials), "Afatinib" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "HCG Bangalore Institute of Oncology" are 11 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "HCG Bangalore Institute of Oncology". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in HCG Bangalore Institute of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HCG Bangalore Institute of Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

HCG Bangalore Institute of Oncology has several departments that took part in Clinical trials: "HCG City Cancer Centre" - 5 trials, "HCG NCHRI Cancer Center" - 4 trials